Related Experiment Video
Updated: Jul 30, 2025

14:09
Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
Published on: March 21, 2013
20.9K
[Medication for Neurogenic Orthostatic Hypotension].
1Department of Neurology, Kanazawa Medical University.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|May 17, 2023
Summary
Orthostatic hypotension, a drop in blood pressure upon standing, can be caused by autonomic failure. This review covers neurogenic orthostatic hypotension diagnosis, treatment, and medications.
Area of Science:
- Neurology
- Cardiology
- Physiology
Background:
- Orthostatic hypotension involves a blood pressure drop when changing posture due to impaired blood volume regulation.
- It is categorized into neurogenic and non-neurogenic forms, with neurogenic orthostatic hypotension linked to autonomic nervous system dysfunction.
- Autonomic failure can manifest in various neurological conditions, making neurogenic orthostatic hypotension a significant clinical challenge.
Approach:
- This review synthesizes current knowledge on neurogenic orthostatic hypotension.
- It details the underlying pathophysiology and diagnostic approaches.
- Therapeutic strategies and pharmacological characteristics are also discussed.
Key Points:
- Neurogenic orthostatic hypotension results from autonomic nervous system failure.
- Accurate diagnosis involves assessing autonomic function and blood pressure responses.
- Management includes non-pharmacological measures and targeted drug therapies.
Conclusions:
- Understanding the pathophysiology of neurogenic orthostatic hypotension is crucial for effective management.
- A comprehensive diagnostic workup aids in identifying the cause and guiding treatment.
- Current therapeutic strategies aim to mitigate symptoms and improve patient quality of life.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
314
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
314
Antihypertensive Drugs: Vasodilators
583
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
583
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
473
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
473
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
427
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
427
Alterations in Blood Pressure
1.3K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.3K
Heart Failure Drugs: β-Blockers
402
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
402

